Table 3.
Subjects / Age | Sample Size | Sex | Study Scope | Major Finding | Citation | Quality of Evidence |
Meta-analysis of 28 studies on schizophrenia; Age of subjects not specified | Not specified | Mixed | Determine the association between APOE and schizophrenia: evidence of systematic review and updated meta-analysis | Protective effect was found for ɛ3 in the Asian population (OR = 0.73, 95% CI = 0.54–0.98) | Gonzalez-Castro et al. [70] | Moderate |
Infants with hypoxic-ischemic encephalopathy | ɛ4 Carriers (N = 41) | Mixed | APOE genotype and outcome in infants with hypoxic-ischemic encephalopathy | Disability was not associated with APOE genotype in this cohort of hypoxic-ischemic encephalopathy patients | Cotton et al. [72] | Moderate |
Pooled analysis of 15 studies on the association of APOE alleles with age-related macular degeneration; Age not specified | Not specified | Mixed | Evidence of association of APOE with age-related macular degeneration–a pooled analysis of 15 studies | Decrease in risk associated with each copy of ɛ4 in all age-related macular degeneration sub-phenotypes (Neovascular: OR = 0.74, CI 0.66–0.83; Geographic Atrophic: OR = 0.65, CI 0.55–0.77; Geographic Atrophic Neovascular: OR = 0.71, CI 0.59–0.85; early Age-Related Macular Degeneration: OR = 0.84, CI 0.77–0.92 | McKay et al. [71] | High |
Male and female patients, average age 46, from the dermatology clinic at Hospital Universitario Central Asturias, Spain | ɛ3/ɛ4 (N = 54), ɛ4/ɛ4(N = 3), ɛ2/ɛ4(N = 5) | Mixed | APOE4 allele is associated with psoriasis severity | ɛ4 carriers were significantly more common in patients with severe psoriasis compared to controls (p = 0.003) and to non-severe psoriasis (p = 0.017) | Coto-Segura et al. [150] | Moderate |
Children in Brasilia Brazil with and without CP; Age not specified | ɛ4 Carriers (N = 139) | Mixed | Association of APOE genotype and CP | Presence of ɛ2 raised the probability of having cerebral palsy (OR 3.2; 95% CI 1.27–8.27). The presence of ɛ4 was not significantly different among groups | Braga et al. [73] | Moderate |
Infants in Edinburgh Scotland | ɛ4 Carriers (N = 95) | Mixed | APOE ɛ4 and its prevalence in early childhood death due to sudden infant death syndrome or to recognized causes | Percentage of children with at least one ɛ4 allele was lower in non-SIDS compared to SIDS (p = 0.016) | Becher et al. [59] | Moderate |
Caucasian (70%) and African-American children (30%) from Louisville, KY, area, average age 6.4 years | ɛ4 Carriers (N = 19) | Mixed | APOE ɛ4 allele, cognitive dysfunction, and obstructive sleep apnea in children | ɛ4 allele is more frequent in children with obstructive sleep apnea and particularly in children who develop neurocognitive deficits | Gozal et al. [151] | Low |
White, Black, and Hispanic children from the Chicago area; Age not specified | ɛ4 Carriers (N = 25 patients; N = 9 controls) | Mixed | Association of APOE genotype and CP in children | Overall risk for CP was elevated 3.4-fold among children carrying an ɛ4 allele | Kuroda et al. [75] | Low |
40 patients with CP and 40 without, in S’ao Paulo, Brazil; Age not specified | Total N = 80, 40 with CP, 40 without CP; ɛ4 Carriers (N = 13 patients; N = 4 controls) | Mixed | Presence of APOE ɛ4 allele in CP | OR for correlation between CP and ɛ4 allele = 4.333 | de Barros et al. [74] | Low |
APOE, apolipoprotein E; 95% CI, 95% confidence interval; CP, cerebral palsy; OR, odds ratio; SIDS, sudden infant death syndrome.